title: [Vaccine application of recombinant herpesviruses].
abstract: Recently, genetic engineering using recombinant DNA techniques has been applied to design new viral vaccines in order to reduce some problems which the present viral vaccines have. Up to now, many viruses have been investigated for development of recombinant attenuated vaccines or live viral vectors for delivery of foreign genes coding immunogenic antigens. In this article, we introduced the new vaccine strategy using genetically engineered herpesviruses.
authors.affiliation: Laboratory of Viral Oncology, Aichi Cancer Center Research Institute.
authors.forename: N
authors.initials: N
authors.lastname: Yokoyama
authors.forename: X
authors.initials: X
authors.lastname: Xuan
authors.forename: T
authors.initials: T
authors.lastname: Mikami
mesh_terms: D018138:Alphaherpesvirinae / Q000276:immunology*; D000818:Animals; D002415:Cats; D004285:Dogs; D006566:Herpesviridae Infections / Q000517:prevention & control; D006801:Humans; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
chemical_list: D014614:Vaccines, Synthetic; D014765:Viral Vaccines